Taenia Infection Differential Diagnoses

1. Ito A, Wandra T, Sato MO, et al. Towards the international collaboration for detection, surveillance and control of taeniasis/ cysticercosis and echinococcosis in Asia and the Pacific. Southeast Asian J Trop Med Public Health. 2006. 37 Suppl 3:82-90. [QxMD MEDLINE Link].

2. Craig P, Ito A. Intestinal cestodes. Curr Opin Infect Dis. 2007 Oct. 20(5):524-32. [QxMD MEDLINE Link].

3. Del Brutto OH. Human Neurocysticercosis: An Overview. Pathogens. 2022 Oct 20. 11 (10):[QxMD MEDLINE Link]. [Full Text].

4. World Health Organization. Taeniasis/cysticercosis. 2018 Feb 15. [Full Text].

5. Brunetti E, White AC Jr. Cestode infestations: hydatid disease and cysticercosis. Infect Dis Clin North Am. 2012 Jun. 26(2):421-35. [QxMD MEDLINE Link].

6. Sorvillo F, Wilkins P, Shafir S, Eberhard M. Public health implications of cysticercosis acquired in the United States. Emerg Infect Dis. 2011 Jan. 17(1):1-6. [QxMD MEDLINE Link].

7. O'Neal S, Noh J, Wilkins P, Keene W, Lambert W, Anderson J. Taenia solium Tapeworm Infection, Oregon, 2006-2009. Emerg Infect Dis. 2011 Jun. 17(6):1030-6. [QxMD MEDLINE Link].

8. Croker C, Soriano J, Civen R, Larsen RA, Schwartz B, Centers for Disease Control and Prevention (CDC). Notes from the field: identification of a Taenia tapeworm carrier - Los Angeles County, 2014. MMWR Morb Mortal Wkly Rep. 2015 Jan 30. 64 (3):74. [QxMD MEDLINE Link]. [Full Text].

9. O'Keefe KA, Eberhard ML, Shafir SC, Wilkins P, Ash LR, Sorvillo FJ. Cysticercosis-related hospitalizations in the United States, 1998-2011. Am J Trop Med Hyg. 2015 Feb. 92 (2):354-9. [QxMD MEDLINE Link].

10. Del Brutto OH. Neurocysticercosis. Semin Neurol. 2005 Sep. 25(3):243-51. [QxMD MEDLINE Link].

11. Kanobana K, Praet N, Kabwe C, Dorny P, Lukanu P, Madinga J, et al. High prevalence of Taenia solium cysticerosis in a village community of Bas-Congo, Democratic Republic of Congo. Int J Parasitol. 2011 Aug 15. 41(10):1015-8. [QxMD MEDLINE Link].

12. O'Neal SE, Townes JM, Wilkins PP, Noh JC, Lee D, Rodriguez S. Seroprevalence of Antibodies against Taenia solium Cysticerci among Refugees Resettled in United States. Emerg Infect Dis. 2012 Mar. 18(3):431-8. [QxMD MEDLINE Link].

13. Eichenberger RM, Thomas LF, Gabriël S, et al. Epidemiology of Taenia saginata taeniosis/cysticercosis: a systematic review of the distribution in East, Southeast and South Asia. Parasit Vectors. 2020 May 7. 13 (1):234. [QxMD MEDLINE Link]. [Full Text].

14. Lee MK, Hong SJ, Kim HR. Seroprevalence of tissue invading parasitic infections diagnosed by ELISA in Korea. J Korean Med Sci. 2010 Sep. 25(9):1272-6. [QxMD MEDLINE Link]. [Full Text].

15. Anantaphruti MT, Okamoto M, Yoonuan T, et al. Molecular and serological survey on taeniasis and cysticercosis in Kanchanaburi Province, Thailand. Parasitol Int. 2010 Sep. 59(3):326-30. [QxMD MEDLINE Link].

16. Youn H. Review of zoonotic parasites in medical and veterinary fields in the Republic of Korea. Korean J Parasitol. 2009 Oct. 47 Suppl:S133-41. [QxMD MEDLINE Link]. [Full Text].

17. Carabin H, Millogo A, Praet N, et al. Seroprevalence to the antigens of Taenia solium cysticercosis among residents of three villages in Burkina Faso: a cross-sectional study. PLoS Negl Trop Dis. 2009 Nov 24. 3(11):e555. [QxMD MEDLINE Link]. [Full Text].

18. Openshaw JJ, Medina A, Felt SA, et al. Prevalence and risk factors for Taenia solium cysticercosis in school-aged children: A school based study in western Sichuan, People's Republic of China. PLoS Negl Trop Dis. 2018 May 8. 12(5):e0006465. [QxMD MEDLINE Link]. [Full Text].

19. Balodhi A, Jain K, Gupta P, Deeba F, Salam N. A meta-analysis on the prevalence of Taenia solium and Taenia saginata infections in India. Trans R Soc Trop Med Hyg. 2023 Aug 3. 117 (8):539-45. [QxMD MEDLINE Link].

20. Verma R, Sharma P, Khurana N. Thousands of lesions in disseminated cysticercosis. Am J Trop Med Hyg. 2011 Oct. 85(4):583. [QxMD MEDLINE Link]. [Full Text].

21. Nussinson E, Yair-Sabag S, Shibli F. Detection of Taenia saginata infection mimicking Crohn's disease using video capsule endoscopy. Clin Case Rep. 2018 Mar 4. 6(4):741-744. [QxMD MEDLINE Link]. [Full Text].

22. Fleury A, Carrillo-Mezo R, Flisser A, Sciutto E, Corona T. Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther. 2011 Jan. 9(1):123-33. [QxMD MEDLINE Link].

23. Carpio A. Neurocysticercosis: an update. Lancet Infect Dis. 2002 Dec. 2(12):751-62. [QxMD MEDLINE Link].

24. Garcia HH, Del Brutto OH. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol. 2005 Oct. 4(10):653-61. [QxMD MEDLINE Link].

25. Del Brutto OH, Salgado P, Lama J, Del Brutto VJ, Campos X, Zambrano M, et al. Calcified neurocysticercosis associates with hippocampal atrophy: a population-based study. Am J Trop Med Hyg. 2015 Jan. 92 (1):64-8. [QxMD MEDLINE Link]. [Full Text].

26. Morales NM, Agapejev S, Morales RR, Padula NA, Lima MM. Clinical aspects of neurocysticercosis in children. Pediatr Neurol. 2000 Apr. 22(4):287-91. [QxMD MEDLINE Link].

27. Cárdenas G, Jung H, Ríos C, Fleury A, Soto-Hernández JL. Severe cysticercal meningitis: clinical and imaging characteristics. Am J Trop Med Hyg. 2010 Jan. 82(1):121-5. [QxMD MEDLINE Link]. [Full Text].

28. [Guideline] Zammarchi L, Bonati M, Strohmeyer M, et al. Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis: technical recommendations by the COHEMI project study group. Trop Med Int Health. 2017 Jun 1. 22(7):881-894. [QxMD MEDLINE Link]. [Full Text].

29. Praet N, Verweij JJ, Mwape KE, et al. Bayesian modelling to estimate the test characteristics of coprology, coproantigen ELISA and a novel real-time PCR for the diagnosis of taeniasis. Trop Med Int Health. 2013 Mar 7. 18(5):608-14. [QxMD MEDLINE Link]. [Full Text].

30. Nkouawa A, Sako Y, Okamoto M, Ito A. Simple Identification of Human Taenia Species by Multiplex Loop-Mediated Isothermal Amplification in Combination with Dot Enzyme-Linked Immunosorbent Assay. Am J Trop Med Hyg. 2016 Jun 1. 94(6):1318–1323. [QxMD MEDLINE Link]. [Full Text].

31. Canaval Zuleta HJ, Company Campins MM, Dolz Abadía C. Endoscopy as a diagnostic and therapeutic alternative technique of taeniasis. Rev Esp Enferm Dig. 2016 June. 108(6):371-6. [QxMD MEDLINE Link]. [Full Text].

32. Michelet L, Fleury A, Sciutto E, Kendjo E, Fragoso G, Paris L, et al. Human neurocysticercosis: comparison of different diagnostic tests using cerebrospinal fluid. J Clin Microbiol. 2011 Jan. 49(1):195-200. [QxMD MEDLINE Link]. [Full Text].

33. Lee YM, Handali S, Hancock K, Pattabhi S, Kovalenko VA, Levin A, et al. Serologic diagnosis of human Taenia solium cysticercosis by using recombinant and synthetic antigens in QuickELISA™. Am J Trop Med Hyg. 2011 Apr. 84(4):587-93. [QxMD MEDLINE Link]. [Full Text].

34. Kumar A, Goenka AH, Choudhary A, Sahu JK, Gulati S. Disseminated cysticercosis in a child: whole-body MR diagnosis with the use of parallel imaging. Pediatr Radiol. 2010 Feb. 40(2):223-7. [QxMD MEDLINE Link].

35. Nash TE, Ware JM, Mahanty S. Intraventricular Neurocysticercosis: Experience and Long-Term Outcome from a Tertiary Referral Center in the United States. Am J Trop Med Hyg. 2018 Jun. 98(6):1755-1762. [QxMD MEDLINE Link]. [Full Text].

36. Garcia HH, Gonzalez AE, Gilman RH. Cysticercosis of the central nervous system: how should it be managed?. Curr Opin Infect Dis. 2011 Oct. 24(5):423-7. [QxMD MEDLINE Link].

37. Mazumdar M, Pandharipande P, Poduri A. Does albendazole affect seizure remission and computed tomography response in children with neurocysticercosis? A Systematic review and meta-analysis. J Child Neurol. 2007 Feb. 22(2):135-42. [QxMD MEDLINE Link].

38. Garcia HH, Lescano AG, Lanchote VL, Pretell EJ, Gonzales I, Bustos JA, et al. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. Br J Clin Pharmacol. 2011 Jul. 72(1):77-84. [QxMD MEDLINE Link]. [Full Text].

39. Garcia HH, Gonzales I, Lescano AG, Bustos JA, Zimic M, Escalante D, et al. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis. 2014 Aug. 14 (8):687-95. [QxMD MEDLINE Link].

40. Prodjinotho UF, Lema J, Lacorcia M, et al. Host immune responses during Taenia solium Neurocysticercosis infection and treatment. PLoS Negl Trop Dis. 2020 Apr. 14 (4):e0008005. [QxMD MEDLINE Link]. [Full Text].

41. Stelzle D, Makasi C, Schmidt V, et al. Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study. Infection. 2023 Aug. 51 (4):1127-39. [QxMD MEDLINE Link]. [Full Text].

42. Kelesidis T, Thian N. Multiple Intraventricular Neurocysticercal Cysts Treated with Endoscopy without Antiparasitic Therapy. Am J Trop Med Hyg. 2011 Jul. 85(1):1-2. [QxMD MEDLINE Link].

43. American Academy of Pediatrics. Tapeworm Diseases (Taeniasis and Cysticercosis). Red Book: 2009 Report of the Committee on Infectious Diseases. 28th. Elk Grove Village, IL: American Academy of Pediatrics; 2009. 652-4.

44. Cysticercosis. Spector JM, Gibson TE. Atlas of Pediatrics in the Tropics and Resource-Limited Settings. Elk Grove Village, IL: American Academy of Pediatrics; 2009. 73-76.

45. Barton Behravesh C, Mayberry LF, Bristol JR, et al. Population-based survey of taeniasis along the United States-Mexico border. Ann Trop Med Parasitol. 2008 Jun. 102(4):325-33. [QxMD MEDLINE Link].

Supatida Tengsupakul, MD Assistant Professor, Division of Pediatric Hospital Medicine and Division of Pediatric Infectious Diseases, Department of Pediatrics, USA Children's and Women's Hospital, University of South Alabama College of Medicine

Supatida Tengsupakul, MD is a member of the following medical societies: Alabama Chapter of the American Academy of Pediatrics, American Academy of Pediatrics, American Academy of Pediatrics, Section on Hospital Medicine, HIV Medicine Association, Infectious Diseases Society of America, Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Russell W Steele, MD Clinical Professor, Tulane University School of Medicine; Staff Physician, Ochsner Clinic Foundation

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, Southern Medical Association

Disclosure: Nothing to disclose.

Ashir Kumar, MD, MBBS FAAP, Professor Emeritus, Department of Pediatrics and Human Development, Michigan State University College of Human Medicine

Ashir Kumar, MD, MBBS is a member of the following medical societies: Infectious Diseases Society of America, American Association of Physicians of Indian Origin

Disclosure: Nothing to disclose.

Sowmya Nanjappa, MD Assistant Member, Department of Internal Medicine, Moffitt Cancer Center; Assistant Professor of Medicine, Department of Internal Medicine and Department of Oncologic Sciences (Joint Appointment), University of South Florida Morsani College of Medicine

Sowmya Nanjappa, MD is a member of the following medical societies: American Association of Physicians of Indian Origin, American College of Physicians, American Medical Association, Infectious Diseases Society of America, Society of Hospital Medicine

Disclosure: Nothing to disclose.

Leslie L Barton, MD Professor Emerita of Pediatrics, University of Arizona College of Medicine

Leslie L Barton, MD is a member of the following medical societies: American Academy of Pediatrics, Association of Pediatric Program Directors, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Michael D Nissen, MBBS, FRACP, FRCPA Associate Professor in Biomolecular, Biomedical Science & Health, Griffith University; Director of Infectious Diseases and Unit Head of Queensland Paediatric Infectious Laboratory, Sir Albert Sakzewski Viral Research Centre, Royal Children's Hospital

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article